← All posts
Product

Introducing Rapid MCP

Bring RapidAccess into the AI assistant your team already uses. Ask market access questions in plain English and get answers built on curated Canadian regulatory, HTA, negotiation and coverage data, with the sources to back them.

RapidAccess.ai team
A black monolith engraved with RAPID MCP against a starry night sky

Your team already uses AI. The hard part is getting it to give answers you can stand behind.

General-purpose assistants are good at writing and reasoning, but ask one when a drug cleared pCPA, or what CDA-AMC said about its comparator, and it will guess from web pages and memory. In market access, a confident wrong date or a misread recommendation is worse than no answer.

Rapid MCP connects your AI assistant to RapidAccess. The same curated intelligence behind our platform is now available wherever your team works with AI. Ask in plain English. The answers come from RapidAccess, with the source documents attached.

Works with the assistant you already use

Rapid MCP is built on the Model Context Protocol (MCP), the open standard AI assistants use to connect to outside data. Any assistant that supports MCP connectors can use it, including Claude and ChatGPT. Your team doesn’t have to switch tools, and you aren’t tied to one AI vendor. If you change providers or use several, RapidAccess comes with you.

Your market access intelligence, in every conversation

Answers grounded in curated data

Rapid MCP covers the Canadian access pathway from end to end: Health Canada approvals, CDA-AMC reviews, pCPA negotiations, INESSS evaluations and provincial formulary coverage, plus US FDA approvals for comparison. Drugs, sponsors and reviews are matched across agencies, so your assistant can follow a molecule from approval to listing without anyone stitching spreadsheets together.

Every claim traceable to its source

When your assistant quotes a committee rationale, a required price reduction or a coverage criterion, it links to the public report it came from. Analysts can check the evidence in seconds, and anything that goes into a deck or a submission is backed by the original document.

Your access, your permissions

People connect with their own RapidAccess account, and access follows your organization’s subscription. The connection is read-only. Your assistant can look things up, but it can’t change anything.

What teams use it for

Launch planning. “How long have recent rare-disease drugs taken from Health Canada approval to a pCPA agreement?” Get benchmark timelines for your therapeutic area in minutes, not days.

Analog research. “For the last few reviews in this indication, what did the committee say about single-arm evidence?” Pull the relevant committee reasoning across a set of analogs, with citations.

Pricing strategy. “What price reductions has CDA-AMC required for recent oncology drugs, and how did the negotiations end?” See what the agencies have actually asked for before you set expectations internally.

Coverage checks. “Is this gene therapy funded in BC, Ontario and Alberta, and under what criteria?” Get province-by-province answers covering drug plans, cancer agencies and rare-disease programs, and see which provinces haven’t listed it.

Board and leadership updates. Turn a question into a table, a summary or a first-draft slide in the same conversation, built on data your team trusts.

Built for how your team already works

There’s no new tool to learn. Questions, follow-ups and drafts all happen in the assistant your team already writes in. When a question needs more depth, the full RapidAccess platform is one click away, backed by the same data.

Availability

Rapid MCP is available now to RapidAccess customers. Existing customers will find setup instructions in the RapidAccess app. To add Rapid MCP to your subscription or see it answer your own questions, book a demo.

See RapidAccess in action

CDA-AMC reviews, pCPA negotiations, INESSS evaluations and provincial coverage, all in one place.

Book a Demo